Isagro sales up 22% in Q3 2014

Isagro’s sales posted a 22.3% increase to €29.4 million in the third quarter ended Sep 30, 2014. For the first nine months of 2014, the sales increased by 20.8% to €102.3 million,which have been characterized by the recovery of sales versus 2013 (a year which was negatively affected by the "carried-over” effect of 2012 drought) and by the start of the commercial cooperation with the partner Gowan in USA and in Italy; such elements more than offset a weakening of Group’s sales in Brazil and lower sales of Orthosulfamuron and Valiphenalate (the latter two molecules divested in 2013).

Outlook

Isagro’s sales in the fourth quarter are expected to be lower compared to the same period of last year, due to reduced year-end purchases by the distribution systems in Brazil (due to consumption of existing stock and to a weakening of market conditions for Isagro’s products) and in Italy (to limit year-end stocks).